Market Cap ₹54 Cr.
Stock P/E 27
P/B 0.6
Current Price ₹150
Book Value ₹ 234.5
Face Value 10
52W High ₹207.9
Dividend Yield 0%
52W Low ₹ 135
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 41 | 31 | 17 | 34 | 60 | 36 | 10 | 38 | 42 | 25 |
Other Income | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Income | 41 | 31 | 18 | 34 | 60 | 36 | 10 | 38 | 42 | 25 |
Total Expenditure | 39 | 30 | 17 | 38 | 48 | 34 | 10 | 35 | 39 | 24 |
Operating Profit | 2 | 2 | 1 | -5 | 12 | 2 | -0 | 3 | 4 | 1 |
Interest | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 1 | 1 | 0 | -5 | 11 | 1 | -1 | 1 | 3 | 0 |
Provision for Tax | 0 | 0 | 0 | -1 | 3 | 0 | -0 | 0 | 1 | 0 |
Profit After Tax | 1 | 0 | 0 | -4 | 8 | 1 | -1 | 1 | 2 | -0 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 |
Profit After Adjustments | 1 | 0 | 0 | -4 | 8 | 1 | -1 | 1 | 2 | -0 |
Adjusted Earnings Per Share | 1.8 | 0.3 | 0.1 | -10.9 | 22 | 1.9 | -2.3 | 3.1 | 5.7 | -0.9 |
#(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 72 | 78 | 63 | 69 | 72 | 73 | 61 | 117 | 147 | 115 | 115 |
Other Income | 1 | 9 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 |
Total Income | 73 | 87 | 63 | 69 | 72 | 73 | 61 | 117 | 148 | 116 | 115 |
Total Expenditure | 67 | 75 | 55 | 61 | 63 | 66 | 54 | 108 | 137 | 108 | 108 |
Operating Profit | 6 | 12 | 8 | 8 | 9 | 7 | 8 | 9 | 11 | 8 | 8 |
Interest | 6 | 7 | 7 | 5 | 5 | 4 | 3 | 3 | 3 | 3 | 4 |
Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
Exceptional Income / Expenses | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | -1 | 4 | 1 | 2 | 3 | 2 | 3 | 4 | 7 | 3 | 3 |
Provision for Tax | -2 | 2 | 0 | 1 | 1 | -0 | 1 | 2 | 2 | 1 | 1 |
Profit After Tax | 1 | 2 | 0 | 2 | 1 | 2 | 2 | 3 | 5 | 2 | 2 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 1 | 2 | 0 | 2 | 1 | 2 | 2 | 3 | 5 | 2 | 2 |
Adjusted Earnings Per Share | 0 | 0 | 0 | 0 | 3.9 | 5.9 | 6.9 | 7.6 | 13 | 5.6 | 5.6 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | -22% | 24% | 10% | 0% |
Operating Profit CAGR | -27% | 0% | -2% | 0% |
PAT CAGR | -60% | 0% | 15% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | -3% | 14% | 13% | NA% |
ROE Average | 2% | 4% | 4% | 9% |
ROCE Average | 6% | 8% | 7% | 9% |
#(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 61 | 56 | 68 | 70 | 71 | 73 | 75 | 78 | 83 | 85 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 14 | 13 | 10 | 10 | 15 | 14 | 4 | 11 | 15 | 13 |
Other Non-Current Liabilities | -3 | -1 | 1 | 1 | 2 | 1 | 2 | 1 | 0 | 0 |
Total Current Liabilities | 45 | 59 | 43 | 43 | 41 | 26 | 28 | 21 | 43 | 22 |
Total Liabilities | 117 | 127 | 122 | 124 | 129 | 115 | 108 | 111 | 140 | 119 |
Fixed Assets | 69 | 71 | 82 | 81 | 81 | 81 | 80 | 71 | 70 | 69 |
Other Non-Current Assets | 1 | 1 | 1 | 2 | 2 | 3 | 3 | 11 | 11 | 11 |
Total Current Assets | 48 | 55 | 39 | 41 | 46 | 31 | 25 | 29 | 59 | 39 |
Total Assets | 117 | 127 | 122 | 124 | 129 | 115 | 108 | 111 | 140 | 119 |
#(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 2 | 2 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
Cash Flow from Operating Activities | 2 | -3 | 15 | 9 | 4 | 20 | 12 | 6 | -11 | 16 |
Cash Flow from Investing Activities | 1 | -1 | -1 | -1 | -1 | -2 | -0 | -2 | -5 | 6 |
Cash Flow from Financing Activities | -3 | 4 | -15 | -8 | -3 | -17 | -13 | -4 | 15 | -16 |
Net Cash Inflow / Outflow | 0 | 0 | -0 | -0 | 0 | 1 | -1 | -0 | -0 | 6 |
Closing Cash & Cash Equivalent | 2 | 2 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 6 |
# | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 0 | 0 | 0 | 0 | 3.95 | 5.89 | 6.89 | 7.63 | 13.04 | 5.56 |
CEPS(Rs) | 5.15 | 7.57 | 4.08 | 7.09 | 7.08 | 8.84 | 9.81 | 10.54 | 15.9 | 8.31 |
DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | 0 | 0 | 0 | 0 | 197.02 | 202.62 | 209.16 | 216.62 | 229.61 | 234.49 |
Core EBITDA Margin(%) | 6.83 | 3.78 | 11.62 | 10.66 | 11.24 | 8.93 | 10.84 | 6.46 | 6.05 | 5.58 |
EBIT Margin(%) | 7.19 | 13.58 | 10.71 | 9.79 | 10.12 | 7.74 | 9.51 | 6.04 | 6.26 | 5.22 |
Pre Tax Margin(%) | -1.51 | 4.49 | 0.94 | 2.86 | 3.54 | 2.51 | 5.1 | 3.39 | 4.08 | 2.49 |
PAT Margin (%) | 1.21 | 2.14 | 0.69 | 2.02 | 1.84 | 2.69 | 3.62 | 2.18 | 2.93 | 1.6 |
Cash Profit Margin (%) | 2.58 | 3.47 | 2.14 | 3.39 | 3.3 | 4.05 | 5.16 | 3 | 3.58 | 2.39 |
ROA(%) | 0.75 | 1.38 | 0.38 | 1.24 | 1.13 | 1.74 | 2.23 | 2.51 | 3.73 | 1.54 |
ROE(%) | 28.06 | 42.49 | 1.31 | 2.21 | 2.03 | 2.95 | 3.35 | 3.59 | 5.84 | 2.4 |
ROCE(%) | 11.61 | 21.25 | 8.93 | 6.86 | 7.22 | 5.83 | 6.86 | 8.3 | 9.61 | 5.92 |
Receivable days | 120.71 | 126.02 | 141.64 | 104.9 | 93.13 | 74.11 | 54.49 | 12.94 | 15.4 | 25.87 |
Inventory Days | 81.95 | 75.17 | 69.28 | 50.77 | 67.08 | 66.73 | 61.79 | 35.31 | 49.26 | 69.51 |
Payable days | 140.26 | 129.77 | 146.18 | 101.09 | 112.26 | 110.41 | 121.63 | 44.89 | 45.43 | 60.36 |
PER(x) | 0 | 0 | 0 | 0 | 14.73 | 13.99 | 8.96 | 12.18 | 12.85 | 28.6 |
Price/Book(x) | 0 | 0 | 0 | 0 | 0.3 | 0.41 | 0.3 | 0.43 | 0.73 | 0.68 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 0.6 | 0.67 | 0.69 | 0.57 | 0.82 | 0.74 | 0.61 | 0.4 | 0.62 | 0.62 |
EV/Core EBITDA(x) | 6.87 | 4.49 | 5.16 | 4.67 | 6.6 | 7.49 | 4.92 | 5.32 | 8.24 | 9.41 |
Net Sales Growth(%) | 0 | 9.56 | -20.08 | 10.25 | 4.26 | 1.21 | -16 | 90.44 | 26.08 | -21.78 |
EBIT Growth(%) | 0 | 106.89 | -31.16 | 0.3 | 6.11 | -22.14 | 6.97 | 17.13 | 31.28 | -34.89 |
PAT Growth(%) | 0 | 93.64 | -71.75 | 220.08 | -6.6 | 49.08 | 17.05 | 10.76 | 70.8 | -57.36 |
EPS Growth(%) | 0 | 0 | 0 | 0 | 0 | 49.08 | 17.04 | 10.76 | 70.8 | -57.36 |
Debt/Equity(x) | 13.34 | 10.61 | 0.59 | 0.53 | 0.55 | 0.35 | 0.21 | 0.19 | 0.4 | 0.24 |
Current Ratio(x) | 1.05 | 0.94 | 0.91 | 0.95 | 1.1 | 1.18 | 0.91 | 1.36 | 1.37 | 1.79 |
Quick Ratio(x) | 0.69 | 0.66 | 0.68 | 0.69 | 0.69 | 0.75 | 0.49 | 0.76 | 0.67 | 1.01 |
Interest Cover(x) | 0.83 | 1.49 | 1.1 | 1.41 | 1.54 | 1.48 | 2.15 | 2.28 | 2.88 | 1.91 |
Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 1.87 | 0.87 | 0.71 | 0.44 | 0.55 | 0.35 |
# | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 68.91 | 68.91 | 68.91 | 68.91 | 68.91 | 68.91 | 68.91 | 68.91 | 69.7 | 69.74 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 7.9 | 7.84 | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 |
Public | 23.2 | 23.25 | 23.29 | 23.29 | 23.29 | 23.29 | 23.29 | 23.29 | 22.5 | 22.46 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
Public | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About